First introduced clinically in 2011 [1], combined positron emission and computed tomography (PET/CT) using the PSMA-radioligand [68 Ga]Ga-PSMA-11 has established itself as the gold standard for the imaging of recurrent PC. This evidence concerns the gene FOLH1 and pachyonychia congenita.